Stonegate Investment Group LLC Lowers Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Stonegate Investment Group LLC decreased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 3.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,712 shares of the medical equipment provider’s stock after selling 103 shares during the quarter. Stonegate Investment Group LLC’s holdings in Intuitive Surgical were worth $1,416,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. State Street Corp increased its position in shares of Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after purchasing an additional 210,363 shares in the last quarter. FMR LLC raised its holdings in shares of Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after acquiring an additional 838,793 shares during the period. Geode Capital Management LLC increased its position in Intuitive Surgical by 1.9% during the third quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock worth $3,677,194,000 after purchasing an additional 143,440 shares during the last quarter. Fisher Asset Management LLC grew its stake in shares of Intuitive Surgical by 1.8% in the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock valued at $2,349,441,000 after buying an additional 86,208 shares during the period. Finally, Baillie Gifford & Co. raised its position in shares of Intuitive Surgical by 0.6% during the 3rd quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock valued at $1,890,676,000 after buying an additional 24,183 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of several research analyst reports. Raymond James boosted their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Bernstein Bank boosted their target price on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday. Piper Sandler restated an “overweight” rating and set a $670.00 price target (up from $538.00) on shares of Intuitive Surgical in a research note on Friday. Finally, BTIG Research boosted their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $613.10.

View Our Latest Analysis on Intuitive Surgical

Intuitive Surgical Trading Down 1.8 %

Shares of NASDAQ ISRG opened at $573.48 on Tuesday. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The stock has a market cap of $204.26 billion, a price-to-earnings ratio of 92.20, a PEG ratio of 5.19 and a beta of 1.39. The company’s 50-day moving average price is $547.16 and its 200 day moving average price is $505.21.

Insider Buying and Selling

In other news, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,967,734. The trade was a 6.39 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction on Friday, November 8th. The shares were sold at an average price of $525.00, for a total value of $12,024,075.00. Following the completion of the transaction, the insider now owns 8,757 shares in the company, valued at $4,597,425. The trade was a 72.34 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 42,265 shares of company stock worth $21,964,281. 0.90% of the stock is owned by corporate insiders.

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

See Also

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.